Live Breaking News & Updates on Allorion Therapeutics Inc

Stay updated with breaking news from Allorion therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Argo, Novartis sign two deals for CV assets for potentially $4B+

Announcing two licensing deals with Swiss pharma giant Novartis AG, Shanghai-based Argo Biopharmaceutical Co. Ltd. said on Jan. 7 that it stands to gain up to $4.165 billion for two of its cardiovascular assets combined. Marking the “first significant overseas out-licensing transaction in the RNAi field from a Chinese biotech company,” the deal includes an up-front payment of $185 million from Novartis to Argo. ....

Argo Biopharmaceutical Co , Shanghai Based Argo Biopharmaceutical , Novartis Ag , Shanghai Argo Biopharmaceutical Co Ltd , Argo Biopharmaceutical Co Ltd , Metabolic Disease , Advanced Rna Interface Technology , Suzhou Ribo Life Science Co Ltd , Allorion Therapeutics Inc , Medilink Therapeutics Co Ltd ,